A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)

NCT06024746 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Finerenone
DRUG: Empagliflozin

Sponsor

Colorado Prevention Center

Collaborators

[object Object]
[object Object]